Dabigatran Impurity 76 | CAS 2931469-62-2 - Request Quote
Dabigatran Impurity 76
| SZ CAT No: | SZ-D012179 |
| CAS No | 2931469-62-2 |
| Mol.F. | C16H16N4O5 |
| Mol.Wt. | 344.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 76 is chemically 3-(4-(Methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoic acid. Dabigatran Impurity 76 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 76 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2931469-62-2
Purchase 2931469-62-2
Order 2931469-62-2
Enquire 2931469-62-2
price of 2931469-62-2
2931469-62-2 Supplier
2931469-62-2 Manufacturer
2931469-62-2 Exporter
buy high quality Dabigatran Impurity 76
Purchase Dabigatran Impurity 76
Dabigatran Impurity 76 suppliers
Dabigatran Impurity 76 manufacturers
Dabigatran Impurity 76 price
Order Dabigatran Impurity 76
Enquire Dabigatran Impurity 76
Dabigatran Impurity 76 cost
Dabigatran Impurity 76 Supplier
Dabigatran Impurity 76 Distributor
Dabigatran Impurity 76 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 76 for ANDA Filing
Dabigatran Impurity 76 for Forced Degradation Studies
Dabigatran Impurity 76 Identification Standards
Dabigatran Impurity 76 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


